Dennis Zerby
Impact in
- Ophthalmology top 10%
- Retinal Diseases and Treatments
-
- Viral-associated cancers and disorders
Papers in
-
- RNA Research and Splicing 5
- Genomics and Chromatin Dynamics 3
- RNA modifications and cancer 3
- RNA Interference and Gene Delivery 2
- Advanced biosensing and bioanalysis techniques 1
- Oncology 4
- Viral-associated cancers and disorders 3
- Co-authors
- Paul M. Lieberman (6 shared papers)Josef Ozer (3 shared papers)Chi‐Ju Chen (2 shared papers)Gwénaël Jan (1 shared paper)Susan Campbell (1 shared paper)Paul A. Moore (1 shared paper)Michael J. Kadan (3 shared papers)Katherine Mitsouras (1 shared paper)
- Journals
- Nucleic Acids Research (2 papers)Molecular and Cellular Biology (2 papers)Molecular Therapy (1 paper)Methods (1 paper)Human Gene Therapy (1 paper)
- Partner nations
- United StatesUnited KingdomIndia
In The Last Decade
Dennis Zerby
11 papers receiving 408 citations
Peers
Comparison fields: 5 of 55
- Ophthalmology 55
- Oncology 119
- Molecular Biology 289
- Virology 12
- Genetics 66
Countries citing papers authored by Dennis Zerby
This map shows the geographic impact of Dennis Zerby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis Zerby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis Zerby more than expected).
Fields of papers citing papers by Dennis Zerby
This network shows the impact of papers produced by Dennis Zerby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis Zerby. The network helps show where Dennis Zerby may publish in the future.
Co-authors
The 25 scholars most cited alongside Dennis Zerby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 109 | |
| 2 | 1999 | 82 | |
| 3 | 1999 | 60 | |
| 4 | 1998 | 50 | |
| 5 | 1997 | 36 | |
| 6 | 2001 | 27 | |
| 7 | 2001 | 21 | |
| 8 | 1997 | 10 | |
| 9 | 2003 | 10 | |
| 10 | 1996 | 8 | |
| 11 | 1997 | 8 |
About Dennis Zerby
Dennis Zerby is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Genetics and Virology, having authored 11 papers that have together received 421 indexed citations. Recurring topics across this work include RNA Research and Splicing (5 papers), Viral-associated cancers and disorders (3 papers), Genomics and Chromatin Dynamics (3 papers), RNA modifications and cancer (3 papers), Lymphoma Diagnosis and Treatment (2 papers), RNA Interference and Gene Delivery (2 papers), Advanced biosensing and bioanalysis techniques (1 paper) and HIV Research and Treatment (1 paper). The work is most often cited by research in Ophthalmology (55 citations), Oncology (119 citations), Molecular Biology (289 citations), Virology (12 citations) and Genetics (66 citations). Dennis Zerby has collaborated with scholars based in United States, United Kingdom and India. Frequent co-authors include Paul M. Lieberman, Josef Ozer, Chi‐Ju Chen, Gwénaël Jan, Susan Campbell, Paul A. Moore, Michael J. Kadan, Katherine Mitsouras, Dan Lee and Ramin Shiekhattar. Their work appears in journals such as Nucleic Acids Research, Molecular and Cellular Biology, Molecular Therapy, Methods and Human Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.